They Just Don't Get...
Health Care: Drugs
NPS Pharmaceuticals Inc (NPSP: NASDAQ)
$7.85 -0.06 | -0.76%
05/24/12 - 04:00 PM ET
559.78K / 539.70K
Vol / Avg. Vol:7.91 / 7.91
Open / Prev. Close:7.75 - 8.15
Today's Range:4.35 - 10.33
52 Wk Range:18.66%
Performance YTD:TheStreet Rating:
Portfolios with NPSP
- Portfolio NameUser Type
- Userchinahound2
- ContributorBreakout Stocks Of The Week...
- Usersalvatore Portfolio 1
- UserRocket Stocks for the week ...
- UserNICAZ
- UserRocket Stocks for the week ...
- ContributorCharts of the Week - 2-03-2009
- Usertuna's picks
- UserRAPTOR SPRTD-1010081910
- UserRAPTOR 230 SPRTD
Latest NPSP Headlines from TheStreet
- Stocks Under $10: Healthcare Name on Sale
05.17.12 | 07:05 am - 26 Drugs Facing FDA Approval in 2012 05.02.12 | 01:05 pm
- Stocks Under $10: Value Biotech Stock 11.08.11 | 02:11 pm
- NPS Stock Falls On Unusually High Volume (NPSP) 11.07.11 | 01:11 pm
- Phase III a success for Rare Endocrine Disease Drug. Will Investors Agree? 11.07.11 | 01:11 pm
- NPS Pharma: Another Phase III Success 11.07.11 | 07:11 am
- NPS Stock Gaps Down On Today's Open (NPSP) 10.31.11 | 10:10 am
- NPS Pharma: Positive Gattex Data Presented 05.10.11 | 09:05 am
- Biotech Calendar: Key Dates for May 05.02.11 | 09:05 am
- 5 Stocks Setting Up to Break Out 04.29.11 | 02:04 pm
Press Releases for NPSP
- Digestive Disease Week Presentations Support Therapeutic Potential For Gattex (teduglutide) As Novel Treatment For Adult Short Bowel Syndrome - Business Wire 05.21.12 | 08:05 am
- NPS Pharmaceuticals Reports First Quarter 2012 Financial Results - Business Wire 05.03.12 | 04:05 pm
- NPS Pharmaceuticals Reports Four Additional Patients Achieve Independence From Parenteral Support In STEPS 2 Study Of Gattex® In Adult Short Bowel Syndrome - Business Wire 05.03.12 | 08:05 am
- NPS Pharmaceuticals To Report First Quarter 2012 Financial Results - Business Wire 04.27.12 | 08:04 am
- NPS Pharmaceuticals Among 100 Best Places To Work In New Jersey - Business Wire 04.26.12 | 08:04 am
- NPS Pharmaceuticals To Present At Needham Healthcare Conference - Business Wire 03.27.12 | 04:03 pm
- NPS Pharmaceuticals To Present At Barclays Capital Global Healthcare Conference - Business Wire 03.07.12 | 04:03 pm
- NPS Pharmaceuticals Appoints Georges Gemayel, Ph.D., To Board Of Directors - Business Wire 02.29.12 | 08:02 am
- NPS Pharmaceuticals Observes Rare Disease Day 2012 - Business Wire 02.27.12 | 08:02 am
- NPS Pharmaceuticals To Present At Upcoming Conferences - Business Wire 02.21.12 | 04:02 pm
Partner Headlines for NPSP
- 10 Biotech Stocks With Strong Corporate Governance - Seeking Alpha 01.18.12 | 09:01 am
- 6 Biotechs That Could See Huge Gains (Like Inhibitex) - Seeking Alpha 11.11.11 | 09:11 am
- End-of-Day Market Summary for October 31, 2011 - Benzinga 10.31.11 | 04:10 pm
- Spectrum Pharmaceuticals: A Great Biotech Company For Around $8 - Seeking Alpha 08.26.11 | 05:08 am
- Top 20 Oversold Stocks Being Bought by Smart Money - Seeking Alpha 11.24.10 | 09:11 am
- 14 Short Ideas for Next Week - Seeking Alpha 09.10.10 | 06:09 pm
- Best Performing Russell 3000 Stocks Year to Date - SeekingAlpha.com 04.22.10 | 04:04 am
- NPS Pharmaceuticals: Good News on Horizon? - SeekingAlpha.com 03.26.10 | 10:03 am
- Zacks #5 Rank Additions for Thursday - Tale of the Tape - Zacks 03.18.10 | 08:03 am
